Rodan, Gideon A.

Therapeutic Approaches to Bone Diseases

Rodan, G. A., & Martin, T. J. (2000) · Science

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 1,767

Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure.

Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation

Bone health and treatmentsBone Metabolism and Diseases

Cited by 1,004

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

Rodan, G. A., & Martin, T. J. (1981) · Calcified Tissue International

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 982

M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase

Glantschnig, H., Fisher, J. E., Wesolowski, G., Rodan, G. A., & Reszka, A. A. (2003) · Cell Death & Differentiation

Bone Metabolism and DiseasesPI3K/AKT/mTOR signaling in cancer

Cited by 350

Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.

Halasy-Nagy, J. M., Rodan, G. A., & Reszka, A. A. (2001) · Bone

Bone Metabolism and DiseasesBone health and treatments

Cited by 190

M-CSF induces the stable interaction of cFms with αVβ3 integrin in osteoclasts

Elsegood, C. L., Zhuo, Y., Wesolowski, G. A., Hamilton, J. A., Rodan, G. A., & Duong, L. T. (2006) · The International Journal of Biochemistry & Cell Biology

Cell Adhesion Molecules ResearchBone Metabolism and Diseases

Cited by 28

Rat tail skin temperature regulation by estrogen, phytoestrogens and tamoxifen

Opas, E. E., Jane Rutledge, S., Vogel, R. L., Rodan, G. A., & Schmidt, A. (2004) · Maturitas

Estrogen and related hormone effectsPhytoestrogen effects and research

Cited by 25